Export 5 results:
Author Title [ Type(Asc)] Year
Filters: Author is Karuppusamy, Karthik V  [Clear All Filters]
Journal Article
Karuppusamy KV, Babu P, Thangavel S.  2021.  The Strategies and Challenges of CCR5 Gene Editing in Hematopoietic Stem and Progenitor Cells for the Treatment of HIV.. Stem Cell Rev Rep. 17(5):1607-1618. DOI:10.1007/s12015-021-10145-7.
Mahalingam G, Rachamalla HKrishnared, Arjunan P, Karuppusamy KV, Periyasami Y, Mohan A, Subramaniyam K, M S, Rajendran V, Moorthy M, Varghese GM, Mohankumar KM, Thangavel S, Srivastava A, Marepally S.  2024.  SMART-lipid nanoparticles enabled mRNA vaccine elicits cross-reactive humoral responses against the omicron sub-variants.. Mol Ther. DOI:10.1016/j.ymthe.2024.02.028.
Christopher ACrystal, Venkatesan V, Karuppusamy KV, Srinivasan S, Babu P, Azhagiri MKumar K, Chambayil K, Bagchi A, Rajendiran V, Ravi NSam, Kumar S, Marepally SKumar, Mohankumar KMurugesan, Srivastava A, Velayudhan SR, Thangavel S.  2022.  Preferential Expansion of Human CD34CD133CD90 Hematopoietic Stem Cells Enhances Gene-Modified Cell Frequency for Gene Therapy.. Hum Gene Ther. 33(3-4):188-201. DOI:10.1089/hum.2021.089.
Venkatesan V, Christopher ACrystal, Karuppusamy KV, Babu P, Alagiri MKumar K, Thangavel S.  2022.  CRISPR/Cas9 Gene Editing of Hematopoietic Stem and Progenitor Cells for Gene Therapy Applications.. J Vis Exp. (186) DOI:10.3791/64064.
Karuppusamy KV, Demosthenes JPaul, Venkatesan V, Christopher ACrystal, Babu P, Azhagiri MK, Jacob A, Ramalingam VVadhini, Rangaraj S, Murugesan MKumarasamy, Marepally SKumar, Varghese GM, Srivastava A, Kannangai R, Thangavel S.  2022.  The CCR5 Gene Edited CD34(+)CD90(+) Hematopoietic Stem Cell Population Serves as an Optimal Graft Source for HIV Gene Therapy.. Front Immunol. 13:792684. DOI:10.3389/fimmu.2022.792684.